ERS 2023 Archives - Medical Conferences

Home > Pulmonology > ERS 2023

European Respiratory Society 9–13 September 2023 Milan, Italy

Letter from the Editor

Presented By

Prof. em. Richard Dekhuijzen, Radboud University Medical Center, the Netherlands

ERS 2023 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Best of the Posters

sRAGE: A novel potential biomarker to assess the risk of acute respiratory events

Presented By

Dr Jinying Chen, Sichuan University, China

Most severe asthma patients are candidates for biologic therapy on a global scale

Presented By

Dr Freda Yang, Imperial College London, UK

Aspergillus infections: resistance to azole treatment increased in the presence of diesel particles

Presented By

Valentina Huang, Imperial College London, UK

Asthma in 2023

Tapering from high-dose inhaled corticosteroids possible in most asthma patients treated with benralizumab

Presented By

Prof. David J. Jackson, King's College London, UK

Tezepelumab therapy: hints toward a disease-modifying effect?

Presented By

Prof. Christopher Brightling, University of Leicester, UK

Digital inhaler programme improves asthma control also in the long term, but not long-term adherence

Presented By

Susanne J van de Hei, University Medal Center Groningen, the Netherlands

Respiratory health in children

Large infant study demonstrates the importance of a mature microbiome

Presented By

Dr Yuan Gao, Deakin University, Australia

Healthy maternal lifestyle during pregnancy reduces wheezing and rhinitis in infants

Presented By

Dr Alicia Guillien, University of Grenoble Alpes, France

Mechanism of autophagy in a newborn responsible for deleterious effect of air pollutants

Presented By

Dr Olga Gorlanova, University of Basel, Switzerland

COPD: New Developments

Gabapentinoids increase risk of exacerbations in COPD

Presented By

Mr Alvi Rahman, McGill University, Canada

Future treatment of fatigue in COPD: 4 possible targets identified

Presented By

Dr Maarten Van Herck, Ciro, the Netherlands

Pulmonary Consequences of Long COVID

Women at higher risk of functional respiratory complaints following a COVID-19 infection

Presented By

Prof. Thomas Gille, Université Sorbonne Paris Nord, France

Elevated myeloid inflammation and complement activation present in various phenotypes of long COVID

Presented By

Dr Felicity Liew, Imperial College London, UK

Pulmonary Arterial Hypertension (PAH): Novel Developments

Encouraging long-term outcomes observed in the treatment of PAH with sotatercept

Presented By

Prof. Ioanna Preston , Tufts University School of Medicine, MA, USA

Chronic thromboembolic pulmonary hypertension: surgery entails encouraging long-term results

Presented By

Dr Paula Appenzeller, University of Zürich, Switzerland

Women with pulmonary hypertension have better survival chances than men

Presented By

Dr Anna Titz, University Hospital Zürich, Switzerland

Rare Diseases in 2023

Primary ciliary dyskinesia: Idrevloride shows promising results in phase 2 trial

Presented By

Prof. Thomas Ferkol Jr, University of North Carolina, NC, USA

Promising new agent as treatment for pulmonary fibrosis

Presented By

Prof. Tamara Corte, University of Sydney, Australia

Novel immunomodulator offers hope to reduce steroid dependency in sarcoidosis

Presented By

A Chandrasekaran

Other Research of Interest

Tacrolimus versus cyclosporin: Less lung graft dysfunction

Presented By

Prof. Göran Dellgren, Sahlgrenska University Hospital, Sweden

CPAP effective in reducing cardiovascular mortality in a practice study

Presented By

Dr Jordi De Batlle Garcia, Institut de Recerca Biomèdica de Lleida, Spain

Gefapixant curbs chronic cough independent of its duration

Presented By

Prof. Imran Satia, McMaster University, Canada

Medical Conferences

ERS 2023

Table of Contents

Featured articles

Letter from the Editor

ERS 2023 Highlights Podcast

Best of the Posters

sRAGE: A novel potential biomarker to assess the risk of acute respiratory events

Most severe asthma patients are candidates for biologic therapy on a global scale

Aspergillus infections: resistance to azole treatment increased in the presence of diesel particles

Asthma in 2023

Tapering from high-dose inhaled corticosteroids possible in most asthma patients treated with benralizumab

Tezepelumab therapy: hints toward a disease-modifying effect?

Digital inhaler programme improves asthma control also in the long term, but not long-term adherence

Respiratory health in children

Large infant study demonstrates the importance of a mature microbiome

Healthy maternal lifestyle during pregnancy reduces wheezing and rhinitis in infants

Mechanism of autophagy in a newborn responsible for deleterious effect of air pollutants

COPD: New Developments

Gabapentinoids increase risk of exacerbations in COPD

Future treatment of fatigue in COPD: 4 possible targets identified

Pulmonary Consequences of Long COVID

Women at higher risk of functional respiratory complaints following a COVID-19 infection

Elevated myeloid inflammation and complement activation present in various phenotypes of long COVID

Pulmonary Arterial Hypertension (PAH): Novel Developments

Encouraging long-term outcomes observed in the treatment of PAH with sotatercept

Chronic thromboembolic pulmonary hypertension: surgery entails encouraging long-term results

Women with pulmonary hypertension have better survival chances than men

Rare Diseases in 2023

Primary ciliary dyskinesia: Idrevloride shows promising results in phase 2 trial

Promising new agent as treatment for pulmonary fibrosis

Novel immunomodulator offers hope to reduce steroid dependency in sarcoidosis

Other Research of Interest

Tacrolimus versus cyclosporin: Less lung graft dysfunction

CPAP effective in reducing cardiovascular mortality in a practice study

Gefapixant curbs chronic cough independent of its duration